Goldman Sachs & Co.
3414 Peachtree Road, N.E.
Suite 600
Atlanta
Georgia
30326
United States
Tel: 404-846-7200
Website: http://www.gs.com/
449 articles about Goldman Sachs & Co.
-
The money will be funneled into early- to mid-stage therapeutic companies with “multi-asset portfolios” for the “next generation” of biotechs in addition to diagnostic and life sciences tools.
-
Jose Luis Casero Sanchez took advantage of his position in Goldman Sachs’ “control room” to gain insider knowledge of upcoming transactions, including those for several biopharma companies.
-
Upon completion of the merger, Parexel will be owned by EQT IX Fund and the private equity business within Goldman Sachs Asset Management.
-
EQT Private Equity and Goldman Sachs Asset Management to acquire Parexel, a leading global clinical research organization, for USD 8.5 billion
7/2/2021
The EQT IX fund and the Private Equity business within Goldman Sachs Asset Management have agreed to acquire Parexel, a leading global clinical research organization from Pamplona Capital Management for an enterprise value of USD 8.5 billion.
-
Parexel to be Acquired by EQT Private Equity and Goldman Sachs Asset Management
7/2/2021
Parexel, a leading global clinical research organization focused on development and delivery of innovative new therapies to advance patient health, announced the execution of a definitive merger agreement under which it will be acquired by EQT IX fund and the Private Equity business within Goldman Sachs Asset Management from Pamplona Capital Management LP for $8.5 billion.
-
CUREMARK Honored by Goldman Sachs for Entrepreneurship
10/14/2020
Dr. Joan M. Fallon, CEO and Founder Among 100 Most Intriguing Entrepreneurs at 2020 Builders + Innovators Summit
-
Sempre Health Honored By Goldman Sachs For Entrepreneurship
10/17/2019
Founder and CEO Anurati Mathur Among 100 Most Intriguing Entrepreneurs at 2019 Builders + Innovators Summit
-
League Honored by Goldman Sachs for Entrepreneurship
10/16/2019
Mike Serbinis, Founder and CEO, Among 100 Most Intriguing Entrepreneurs at 2019 Builders + Innovators Summit
-
The Medicines Company Announces Launch of Public Offering of Common Stock
6/24/2019
The Company expects to use the net proceeds of the offering to fund its development of inclisiran and for general corporate purposes.
-
Amgen To Present At The Goldman Sachs 40th Annual Global Healthcare Conference
6/7/2019
Amgen will present at the Goldman Sachs 40th Annual Global Healthcare Conference at 11:20 a.m. PT on Wednesday, June 12, 2019, in Rancho Palos Verdes, Calif.
-
Insmed to Present at the Goldman Sachs 40th Annual Global Healthcare Conference
6/6/2019
Insmed Incorporated announced that Will Lewis, Chairman and Chief Executive Officer of Insmed, will present at the Goldman Sachs 40th Annual Global Healthcare Conference in Rancho Palos Verdes on Thursday, June 13, 2019 at 8:00 a.m. PDT.
-
BioMarin to Participate in Goldman Sachs 40th Annual Global Healthcare Conference on Tuesday, June 11 in Rancho Palos Verdes, CA
6/5/2019
BioMarin Pharmaceutical Inc. announced that Henry Fuchs, M.D., President, Worldwide Research & Development, will present at the Goldman Sachs 40th Annual Global Healthcare Conference on Tuesday, June 11 at 8:40am PT/11:40am ET in Rancho Palos Verdes, California.
-
Aimmune to Participate in the Goldman Sachs 40th Annual Healthcare Conference
6/5/2019
Aimmune Therapeutics, Inc. announced that members of its Executive Management Team will participate in a fireside chat at the Goldman Sachs 40th Annual Healthcare Conference on Wednesday, June 12, 2019 at 9:20 a.m. P.D.T.
-
Array BioPharma to Present at the Goldman Sachs 40ᵗʰ Annual Global Healthcare Conference
6/4/2019
Array BioPharma Inc. announced that its Chief Operating Officer, Andrew Robbins, will speak at the Goldman Sachs 40th Annual Global Healthcare Conference in Rancho Palos Verdes, California.
-
Vascular Graft Solutions Honored by Goldman Sachs for Entrepreneurship as Eyal Orion, Its Founder and CEO, is Among 100 Most Intriguing Entrepreneurs at 2018 Builders + Innovators Summit
10/18/2018
Goldman Sachs is recognizing Dr. Eyal Orion, founder and CEO of Vascular Graft Solutions as one of the 100 Most Intriguing Entrepreneurs of 2018 at its Builders + Innovators Summit in Santa Barbara, California.
-
Aldevron Honored by Goldman Sachs for Entrepreneurship
10/17/2018
Michael Chambers, Founder and CEO, Among 100 Most Intriguing Entrepreneurs at 2018 Builders + Innovators Summit
-
New Haven, Connecticut-based Arvinas, only a few months since raising $55 million in a Series C financing, filed for an initial public offering (IPO). The company hopes to raise $100 million.
-
UTILITY therapeutics signs license agreement with LEO Pharma A/S for US rights to mecillinam and pivmecillinam
5/15/2018
UTILITY therapeutics Ltd (“UTILITY” or “the Company”), a pharmaceutical company focused on developing and commercialising antibiotics in the US, today announces the signature of an exclusive license agreement for the antibiotics mecillinam and pivmecillinam with LEO Pharma A/S.
-
Biogen Gained $1 Billion Overnight After Becoming Goldman Sachs' Favorite Biotech
8/17/2017
-
Medtronic Chairman And CEO Omar Ishrak To Speak At Goldman, Sachs & Co. Global Healthcare Conference
5/24/2017